Phosphatidylserine (PS) and Parkinson's Disease: What PubMed Studies Show

By Insight Swarm Research Team, Medical Advisor: Nikhil Joshi, MD, FRCPC

Phosphatidylserine (PS) and Parkinson's Disease: What PubMed Studies Show

PubMed is the primary database of biomedical literature maintained by the National Library of Medicine. This page describes what PubMed-indexed research reveals about Phosphatidylserine (PS) in the context of Parkinson's Disease. This is a research summary — not medical advice. Consult your neurologist or movement disorder specialist.

Volume of Available Research

As of 2026, PubMed contains dozens of relevant publications when searching for "Phosphatidylserine (PS)" combined with "Parkinson's Disease". The current evidence level derived from this literature is: Multiple RCTs in older adults for cognitive decline; FDA qualified health claim (soy-derived)

Types of Studies Available

Given the scientific interest in this combination, the published literature includes a range of study types:

  • In vitro (cell culture) studies: Laboratory investigations of Phosphatidylserine (PS) effects on Parkinson's-relevant cell lines
  • In vivo (animal) studies: Preclinical models examining effects on disease pathways
  • Review articles: Systematic reviews and meta-analyses synthesizing available evidence
  • Clinical studies: Human data from case reports, cohort studies, or clinical trials

How to Search PubMed Yourself

To find the most current and complete literature, use these PubMed search strategies:

  • Basic search: Phosphatidylserine (PS) Parkinson's Disease
  • Advanced search: (Phosphatidylserine (PS)[Title/Abstract]) AND (Parkinson's Disease[Title/Abstract])
  • Filter by article type: Select "Clinical Trial" to focus on human studies
  • Sort by: Most Recent to see latest publications

Interpreting PubMed Results

When reviewing PubMed studies for Phosphatidylserine (PS) and Parkinson's, key considerations include:

  • Study design hierarchy: RCTs > cohort studies > case-control > case reports > animal studies > cell culture
  • Sample size: Small studies (n<50) should be interpreted cautiously
  • Conflict of interest: Check funding sources
  • Replication: Single studies should not change treatment decisions

Medical Disclaimer: This page summarizes published research and is not medical advice. Never start, stop, or change any treatment based on information found online. Always consult qualified healthcare professionals before making treatment decisions.

Get a personalized AI-generated research report at insightswarm.ai.

Frequently Asked Questions

How many PubMed studies exist on Phosphatidylserine (PS) for Parkinson's?

The exact count changes as new research is published. Search pubmed.ncbi.nlm.nih.gov for 'Phosphatidylserine (PS) AND Parkinson's Disease' to get the current count. The evidence level from available literature is: Multiple RCTs in older adults for cognitive decline; FDA qualified health claim (soy-derived).

Are there PubMed clinical trial results for Phosphatidylserine (PS) in Parkinson's?

To find clinical trial publications: go to PubMed, search 'Phosphatidylserine (PS) Parkinson's', then use the 'Article type' filter to select 'Clinical Trial'. Some clinical data exists for this combination.

Can I access the full text of Phosphatidylserine (PS) + Parkinson's studies for free?

Many NIH-funded studies are available free via PubMed Central (PMC). For paywalled articles, try: the author's institution page, ResearchGate, or emailing the corresponding author directly. Some patients also access papers through their hospital library or university networks.